As of November 2024, Synmosa Biopharma Corporation has a market cap of $448.23M. This makes Synmosa Biopharma Corporation the world's 12062th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $465.68M | 0.13% |
2023 | $465.08M | -20.64% |
2022 | $586.01M | 106.36% |
2021 | $283.98M | 3.74% |
2020 | $273.75M | 12.66% |
2019 | $242.98M | -1.61% |
2018 | $246.95M | 16.59% |
2017 | $211.81M | -3.81% |
2016 | $220.21M | -8.37% |
2015 | $240.32M | -4.58% |
2014 | $251.86M | 14.42% |
2013 | $220.12M | 4.99% |
2012 | $209.66M | 60.06% |
2011 | $130.99M | -22.07% |
2010 | $168.09M | -7.60% |
2009 | $181.92M | 84.56% |
2008 | $98.57M | -27.89% |
2007 | $136.70M | - |